TCM
SGNT

Tekla Capital Management’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Tekla Capital Management’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-286,650
Closed -$4.29M – 162
2016
Q2 		$4.29M Hold
286,650
– – 0.18% 97
2016
Q1 		$3.49M Hold
286,650
– – 0.15% 100
2015
Q4 		$4.56M Sell
286,650
-122,850
-30% -$1.93M 0.17% 98
2015
Q3 		$6.28M Hold
409,500
– – 0.23% 91
2015
Q2 		$9.96M Hold
409,500
– – 0.36% 61
2015
Q1 		$9.52M Buy
409,500
+324,000
+379% +$8.58M 0.38% 63
2014
Q4 		$2.15M Sell
85,500
-319,231
-79% -$9.36M 0.1% 85
2014
Q3 		$12.6M Hold
404,731
– – 0.59% 36
2014
Q2 		$10.5M Hold
404,731
– – 0.96% 29
2014
Q1 		$9.46M Buy
404,731
+85,500
+27% +$1.87M 0.95% 30
2013
Q4 		$8.1M Buy
319,231
+49,200
+18% +$1.11M 0.85% 31
2013
Q3 		$5.51M Hold
270,031
– – 0.61% 42
2013
Q2 		$5.67M Buy
+270,031
New +$4.83M 0.77% 36

Tekla Capital Management's SGNT Position: Q3 2016 in Review

Tekla Capital Management sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 286,650 shares — an estimated $4.29M sold.

Tekla Capital Management first reported a position in SGNT in Q2 2013 and held it in 13 quarters. The position peaked at $12.6M in Q3 2014. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Tekla Capital Management reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Tekla Capital Management sold 286,650 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $4.29M.
  • Tekla Capital Management first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q2 2013 and held it in 13 quarters.
  • Tekla Capital Management's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $12.6M in Q3 2014.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Tekla Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.